Overview
- Thai regulators said Hong Thai Herbal Inhaler Formula 2 failed microbial limits for total aerobic count and combined yeasts and moulds, with tests detecting Clostridium perfringens.
- Hong Thai recalled Lot 000332 — 200,000 units made on Dec 9, 2024 and expiring Dec 8, 2027 — after the FDA’s announcement earlier this week.
- The company is retrieving products for destruction in coordination with the FDA, has signaled a Nov 4 disposal date, and is offering refunds or replacements while adding UV sterilisation and tighter quality controls.
- The FDA broadened testing across brands after earlier contamination reports, with another batch from Chama Herbs flagged and the Health Ministry’s lab finding 39 of 54 samples this fiscal year substandard.
- Authorities ordered makers to identify and fix contamination sources before resuming production, and a local outlet reported the FDA has suspended Hong Thai’s manufacturing and may pursue legal action, which officials have not uniformly confirmed.